CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in TARA — Protara Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in TARA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$603,449

-$167,047 QoQ

Shares Held

157,971

+6.8% QoQ

Ownership

0.267%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 118 holders

Holding Since

Dec 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. TARA ranks #252 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$603,449	157,971	+6.8%	Shares	Sole	2026-08-14
2026-03-31	$770,496	147,888	+44.3%	Shares	Sole	2026-05-15
2025-12-31	$546,319	102,499	+7.0%	Shares	Sole	2026-02-13
2025-09-30	$416,616	95,774	0.0%	Shares	Sole	2025-11-10
2025-06-30	$290,195	95,774	+538.5%	Shares	Sole	2025-08-12
2025-03-31	$63,900	15,000	+24.4%	Shares	Sole	2025-09-15
2021-03-31	$189,824	12,060	0.0%	Shares	Sole	2021-05-17
2020-12-31	$291,972	12,060	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.